GlaxoSmithKline Plc's
GlaxoSmithKline expects to report record £1.57 billion in legal fees in the second quarter. The Bloomberg agency writes that it cites a document from the pharmaceutical group with the latest updates on a series of disputes, including those for the drug Avandia, held responsible for heart attacks, and for the antidepressant Paxil.
Il Gazzettino – 16 July 2010 p. 17 
